TCL Archive Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent January 8, 1982
TCL Archive FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer October 20, 1995
TCL Archive Excerpts From A Confidential Report Detailing the I-ELCAP Study’s Design Flaws and Lack of Consent April 29, 2011
